Scoring Method to Identify Low HCC Risk in Patients With Advanced Fibrosis After SVR to HCV Therapy

Source: 2019 Annual Meeting of the American Association for the Study of Liver Diseases*
Download Slideset
November 8-12, 2019; Boston, Massachusetts
External validation supports scoring system for identifying patients with low risk of HCC following SVR.
Format: Microsoft PowerPoint (.ppt)
File Size: 172 KB
Released: November 18, 2019

Acknowledgements

Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@clinicaloptions.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AbbVie
Gilead Sciences, Inc.
Intercept Pharmaceuticals, Inc.

Related Content

Brief Clinical Care Options (CCO) presentation on AASLD guidance on treatment indications and treatment options for pregnant women with chronic HBV infection

Joseph Ahn, MD, MS, MBA Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: July 8, 2021 Expired: July 7, 2022

Download free slides reviewing key data and AASLD guidance on managing HBV infection during pregnancy

Joseph Ahn, MD, MS, MBA Released: July 8, 2021

From Clinical Care Options (CCO), download a PDF featuring expert answers to HCP questions on immunotherapy for patients with advanced HCC

Released: June 29, 2021

Clinical Care Options (CCO) 专家 Grace LH Wong 博士讨论了亚太地区在照护有 HCC 风险的 HBV 患者时的注意事项

Grace LH Wong, MD Released: June 24, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue